Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

IV Interactive Presented With Award for Orthopedic Website Design Innovation


IV Interactive, a digital marketing agency dedicated to medical and healthcare organizations, is the 2023 Gold Award recipient, for its design of The Orthopedic Health Center website, an award-winning orthopedic practice with locations in Hoboken, Jersey City, and Bayonne, NJ.

Now in its 21st year, The Horizon Interactive Awards recognizes excellence in interactive, web, and creative media production. Judging for the Awards is done by a panel of industry professionals, with five criteria being given equal weight: UX/design, creativity, technical, message, and effectiveness.

Of the more than 20,000 worldwide entries submitted, IV Interactive was awarded Gold in the Health/Human Services category, recognizing the best websites, videos, online advertising, print media, and mobile applications in healthcare and wellness.

“Our creative team could not be prouder to have been honored for this website,“ states Dov Radzik, IV Interactive CEO. “Winning the Gold Award for Website Design means that we succeeded in our goal of providing our client with an effective, individualized showcase for patient and physician engagement.”

The website design has allowed The Orthopedic Health Center to better connect with its patients, including English and Spanish-language populations in Hudson County, Northern New Jersey, and New York City. “With the website implementation, we’ve updated our processes and streamlined how we and our patients communicate with each other,” said Dr. Edward Feliciano, Director of Orthopedic Surgery at The Orthopedic Health Center. “We’re able to offer quicker, more direct access to valuable resources, including diagnostic and treatment options, administrative matters, and a full library’s worth of information about common musculoskeletal conditions.”

“We worked closely with The Orthopedic Health Center to craft a website that conveyed the practice’s commitment to its patients,” said Radzik. “Rather than a clinical atmosphere, we presented the doctors as real people, making their patients’ lives better. This is a place where no injury is too small to expect exceptional orthopedic treatment. Whether you have a stubbed toe or a chronic spinal condition, The Orthopedic Health Center will prioritize your care.”

About The Orthopedic Health Center

The Orthopedic Health Center is a full-service orthopedic practice with three locations in Hoboken, Jersey City, and Bayonne, NJ. They specialize in providing exceptional orthopedic care for injuries as well as acute and chronic conditions. Under the direction of renowned orthopedic specialist and surgeon, Dr. Edward Feliciano, the center provides advanced, minimally invasive surgical and non-surgical solutions, including comprehensive orthopedics, sports medicine, complete spine care, and pediatric orthopedics. They diagnose and treat a host of musculoskeletal conditions, including knee pain, shoulder pain, and more. Schedule an appointment today!

About IV Interactive

IV Interactive is a full-service interactive agency specializing in the four major elements required for success in a digital world: innovative design, interactive marketing, technology implementation, and strategic consulting. Using this multidisciplinary approach, the agency provides results-driven, award-winning solutions to healthcare organizations around the world. Which elements are you missing? Visit IVInteractive.com to find out.

Share article on social media or email:

RetireeFirst CEO John Dulczak Selected as Finalist in EY Entrepreneur of the Year 2023 Greater Philadelphia Awards


John Dulczak, founder and CEO of RetireeFirst

I’m honored to be recognized for work that gives me an incredible sense of pride and satisfaction. I’m driven by my passion for providing an excellent healthcare benefits experience for our retiree clients.

Ernst & Young LLP (EY US) recently announced that John P. Dulczak, founder and CEO of RetireeFirst, was selected as a finalist in the Entrepreneur of the Year® 2023 Greater Philadelphia Awards. Now in its 37th year, Entrepreneur of the Year is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable and prosperous world for all.

Dulczak was selected by an independent panel of judges. Entrepreneurs were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth and impact, among other core contributions and attributes.

“I’m honored to be recognized for work that gives me an incredible sense of pride and satisfaction. I’m driven by my passion for providing an excellent healthcare benefits experience for our retiree clients. Our focus will always be helping retirees meet their health and wellness needs while reducing costs and administrative burdens of group retiree plans,” Dulczak said. “I’m thankful to the EY Entrepreneur of the Year Awards committee for seeing the value in what we do and for taking the time to learn more about the motivation behind our company’s amazing journey.”

Founded in 2005, the company quickly made a name for itself as a valuable partner that manages every aspect of group retiree healthcare benefit administration. From plan design and selection to implementation and ongoing benefit administration, RetireeFirst creates a better experience for plan sponsors and helps improve health outcomes for retired members. Following a rebrand to RetireeFirst earlier this year, the company is building on that legacy and upholding its excellent standards.

RetireeFirst has grown significantly the last five years, and company leaders expect that momentum to continue due to the increased demand for its service and skills amid the complex and ever-evolving Medicare landscape. RetireeFirst’s services and solutions are specially designed to support plan sponsors who are challenged with managing benefits budgets and risks while ensuring retiree member needs are met. RetireeFirst Advocates truly care about helping members navigate Medicare, understand their benefits, and connect to programs that can improve their health and wellbeing. The team carries out this mission while maintaining an impressive client retention rate of 100% and achieving an annual net promoter score (NPS) above 90, a significantly higher ranking than the healthcare industry average of 58.

Dulczak and his team are looking forward to June 8, when EY regional award winners will be announced during a special celebration. The winners will then be considered by the national judges for the Entrepreneur of the Year National Awards, which will be presented in November at the annual Strategic Growth Forum® – one of the nation’s most prestigious gatherings of high-growth, market-leading companies. The Entrepreneur of the Year National Overall Award winner will then move on to compete for the EY World Entrepreneur of the Year™ Award in June 2024.

The Entrepreneur of the Year program has recognized more than 11,000 entrepreneurs throughout the US since its inception in 1986, and it has grown to recognize business leaders across 145 cities in over 60 countries around the world.

About RetireeFirst

RetireeFirst is the premier retiree benefit management solutions and advocacy service provider, proven to enhance the experience and outcomes for group plan sponsors and their retirees. Founded in 2005, the company partners with all major national health carriers and hundreds of labor unions, public sector entities, and private corporations nationwide. RetireeFirst designs solutions that preserve and enhance benefit quality while driving material cost savings. Its unparalleled advocacy service creates a seamless benefits experience and connects members to programs that improve their health and wellness. RetireeFirst is HITRUST certified and has been awarded a full URAC Core Accreditation for its commitment to upholding federal regulatory requirements and improving business processes. Headquartered in Mount Laurel, NJ, RetireeFirst’s award-winning team, solutions, and services have received industry praise, world-class NPS scores, and a Philadelphia Biz Journal Best Places to Work award. For more information on RetireeFirst’s people-centric approach, our services, and our broker, consultant, or carrier programs, visit retireefirst.com and follow RetireeFirst on LinkedIn and Twitter.

About Entrepreneur of the Year®

Entrepreneur of the Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur of the Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the EY World Entrepreneur of the Year™ title. Visit ey.com/us/eoy.

Share article on social media or email:

Harris Teeter to Host Drug Take-Back Event on April 22 at several Charlotte-area stores


Harris Teeter will host a drug take-back event at four of its Charlotte locations from 10 a.m. – 2 p.m. on Saturday, April 22, 2023, as part of the U.S. Drug Enforcement Administration’s National Prescription Drug Take-Back Day. These events will provide a safe, convenient and anonymous way for local residents to dispose of unused or expired medications.


  • April 22, 2023 – 10 a.m. – 2 p.m.
  • – Davis Lake – 8445 Davis Lake Parkway, Charlotte, N.C.
  • – Stonecrest – 7852 Rea Road, Charlotte, N.C.
  • – Morrocroft Village – 6701 Morrison Boulevard, Charlotte, N.C.
  • – Smith Farm Road – 4701 Smith Farm Road, Charlotte, N.C.

Harris Teeter has partnered with SAFE KIDS and local law enforcement to assist with the event, which provides Mecklenburg County residents a opportunity to properly dispose of old, unused, or outdated prescription medication in an environmentally and legally safe method. The goal is to help the police department keep medications off the street by proper disposal of prescription medications, and knowing the dangers associated with drug abuse.

You can find more information about Harris Teeter’s commitment to drug disposal solutions on our website.

Since its inception in 2010, DEA’s National Prescription Take Back Day has removed almost 17 million pounds of unneeded medications from communities across the country according to the DEA.

According to the DEA, more than seven million Americans abuse prescription drugs, according to the 2009 Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health. And every day, on average, 2,500 teens use them to get high for the first time, according to the Partnership for a Drug-Free America. Studies show that a majority of abused prescription drugs are obtained from family and friends, including from the home medicine cabinet.

###

About Harris Teeter: For more than 60 years, Harris Teeter, a wholly-owned subsidiary of The Kroger Co. (NYSE: KR), has enriched lives – one meal, one family, one associate, and one community at a time. Headquartered in Matthews, North Carolina, Harris Teeter employs 36,000 valued associates across more than 250 stores and 60 fuel centers in North Carolina, South Carolina, Virginia, Georgia, Maryland, Delaware, Florida, and the District of Columbia.

Share article on social media or email:

World PH Day Amplifies Global Voices United To Cure Pulmonary Hypertension


PHA’s World PH Day theme is “United to Cure PH.”

The Pulmonary Hypertension Association (PHA) joins more than 80 organizations around the world on Friday, May 5, to recognize World PH Day. World PH Day spotlights the global impact of pulmonary hypertension (PH), a rare, complex, life-threatening disease. PH has no cure and affects more than 75 million adults and children of all ethnicities globally. PH, or high blood pressure in the lungs, causes symptoms that include shortness of breath, fatigue and chest pain.

PH is often underdiagnosed, misunderstood or misdiagnosed with more common illnesses, such as asthma. While there is no cure for PH, accurate early diagnosis and access to correct treatment can improve a patient’s quality of life and life expectancy. Without treatment, the average length of survival is under three years.

PH can exist alone or in association with other conditions. In the U.S., PH is most associated with left heart disease. Other PH-associated conditions and risks include connective tissue disorders, blood clots to the lungs, HIV, sickle cell anemia, COPD, sarcoidosis and living in high altitudes. It has also been associated with methamphetamine use.

This year, PHA’s World PH Day theme is “United to Cure PH,” which aims to recognize the global strides made in improving the lives of those affected by PH and highlights the shared goal of finding a cure for the disease. PH can affect anyone regardless of age, sex, race, social or ethnic background. Although the disease is caused by different factors around the world, it affects everyone in a similar way.

“We’ve come a long way since the first therapies for PH were introduced over a decade ago. However, we still have not been able to address the underlying issues that cause PH,” says Matt Granato, PHA president and CEO. “There is much hope ahead though, since new therapies under development aim to stop the progression, or even reverse the damage caused by the disease. It’s truly been a global effort from industry, health care providers, organizations like PHA, caregivers and patients around the world to advance the knowledge and science on PH. Working jointly with a common objective, a brighter future for our community is much closer.”

PHA encourages the global PH community to share what brings them hope in our united efforts towards finding a cure for PH and to help raise awareness on social media through posts using the #WorldPHDay2023 hashtag.

Individuals can visit the World PH Day page on PHA’s website for more information about PH and to learn how they can participate in this year’s campaign. PHA’s World PH Day webpage includes a digital toolkit with educational messages, images and other social media resources. Spanish and French resources are also available.

In the U.S., to raise awareness and advocate on behalf of those with PH, PHA will host virtual legislative visits throughout May beginning on World PH Day, May 5. Advocates will meet with their legislators and ask them to protect access to affordable care by supporting the HELP Copays Act (H.R. 830); support reforms for supplemental oxygen access; and improve benefits management policies by supporting the Safe Step Act (S. 652).

PHA will offer a parallel online opportunity for the PH community to support advocacy efforts on Capitol Hill throughout May. People with PH, their caregivers and loved ones, and health care professionals can use PHA’s Advocacy Action Center to write to their legislators. The PHA email template encourages Congress to reform supplemental oxygen access, ensuring those requiring supplemental oxygen can access the most appropriate type of oxygen for their needs.

PHA will host four in-person events in May:

About the Pulmonary Hypertension Association

Headquartered in Washington, D.C., the Pulmonary Hypertension Association (PHA) is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up- to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit phassociation.org and phassociation.org/worldphday/ and connect with PHA on Twitter, LinkedIn, Instagram and Facebook.

Share article on social media or email:



How Remote Methods Can Deliver Stronger Evidence, Upcoming Webinar Hosted by Xtalks


Within CNS, depression has emerged as a prime candidate for the successful deployment of hybrid DCT models.

The adoption of hybrid decentralized clinical trial models is increasing in many therapeutic areas, and central nervous system (CNS) is topping the list: CNS studies represent roughly 26 percent of all DCTs conducted since 2015, according to GlobalData’s Clinical Trial Database.

Within CNS, depression has emerged as a prime candidate for the successful deployment of hybrid DCT models. In this webinar, the featured speakers will address best practices and draw from their personal experiences, highlighting both the opportunities and the challenges of conducting depression clinical trials.

The convenience, discretion and regularity of reporting associated with remote participation can provide more accurate clinical outcomes while reducing burden on patients. A small, but growing, body of evidence also points to decentralized trials’ facilitation of more truthful self-reporting on suicidality, which — when combined with remote patient monitoring — can make this method a potentially safer option for patients.

Yet many questions remain unanswered: How can study teams ensure that patients are being properly recruited, screened and consented into a decentralized study? How can remote participation be designed to benefit depression patients without jeopardizing data quality? Are the validated instruments commonly used in depression trials suitable for decentralized data collection? How is the placebo effect accounted for in decentralized study designs?

Register now to learn more about delivering stronger evidence in depression clinical trials.

Join Taylor Major, MBA MPH, Senior Implementation Project Manager, ObvioHealth; Jenny Ly, PhD, Senior Clinical Scientist, SPRIM Consultancy; and Faith Matcham, PhD, CPsychol, Health Psychologist and Lecturer in Clinical Psychology, University of Sussex, UK, for the live webinar on Tuesday, May 9, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Depression Clinical Trials: How Remote Methods Can Deliver Stronger Evidence.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)


“This is especially critical given the lack of an FDA-approved neuroprotective drug to address the devastating impacts that stroke can have on patients.” said Dr. Olivia Asfaha, Co-Principal Investigator on the grant.

Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II Small Business Innovation Research (SBIR) grant through the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. The grant will enable late-stage preclinical study of the Company’s neuroprotective peptide tatCN19o by the Stroke Preclinical Assessment Network (SPAN), which was established to address a significant need in the scientific investigation of stroke treatment. The goal of SPAN is to screen and select highly promising treatment candidates for possible further study in human clinical trials. A total of five putative cerebroprotective interventions will be tested in SPAN. With this funding, Neurexis becomes one of only two small business companies that are members of the SPAN program.

Neurexis was formed in early 2020 based on the efforts of Dr. Ulli Bayer at the University of Colorado Anschutz Medical Campus to create an optimized neuroprotective drug called tatCN19o. In both small and large animal studies, the therapeutic prevents neuronal cell death and the associated cognitive and behavioral problems resulting from ischemia caused by stroke or cardiac arrest.

“Neurexis Therapeutics considers the reliability and reproducibility of preclinical data to be of the utmost importance in drug development. Thus, we are thrilled to be part of SPAN 2.0 for continued external validation of our lead therapeutic tatCN19o,” said Dr. Olivia Asfaha, Co-Principal Investigator on the grant. “This program will use high-powered, unbiased testing to conduct direct comparison studies of tatCN19o and other stroke interventions to help expand the very limited clinical toolbox available to physicians and patients for treatment of stroke. This is especially critical given the lack of an FDA-approved neuroprotective drug to address the devastating impacts that stroke can have on patients.”

The award is funded by NINDS of the NIH under grant number U44NS132339.

About Neurexis Therapeutics, Inc.

Stroke and cardiac arrest affect millions of patients each year. Although lifesaving, re-establishing blood flow to the brain does not address the substantial impact on quality of life and healthcare costs associated with the resulting neuronal death and cognitive impairment. At this time, there are no FDA-approved drugs for this indication, resulting in a tremendous unmet medical need for a product such as tatCN19o that significantly reduces brain damage from stroke. To learn more, visit neurexistherapeutics.com.

Share article on social media or email:

Done. rolls out largest technology-driven national platform for holistic in-person and virtual chronic psychiatric care


News Image

An industry first, Done. has reimagined today’s mental-health solutions with a revolutionary hybrid platform designed to tackle psychiatric care. Through an innovative and holistic approach, Done. now allows anyone to tap into the best of both virtual and in-person treatments to better help patients and clinicians achieve better clinical outcomes.

The new platform combines 200+ in-person offices through a blended use of trusted clinical partnerships and virtual care. As a result, Done. now meets patients whenever and wherever they are to deliver world-class psychiatric care nationwide. Hybrid care is defined as a combination of in-person with virtual coverage to provide a holistic option for the patient and provider to achieve the greatest clinical outcomes possible. Done. achieves this fusion of coverage through a “direct” and collaborative care model. It merges Done.’s ongoing virtual care experience with high-touch in-person care conducted by Done.’s clinician consultations at Done. offices, through partner clinician in-person consultations, and via trusted provider referrals to distribute access to the best psychiatric care available.

Done’s mission has always been to empower and support our members in reaching their potential. We started Done because there was a lack of qualified clinicians to treat patients and because patients struggled to access care within their communities. As the Biden administration announced on January 30, 2023, the COVID-19 public-health emergency (PHE) will end on May 11, 2023.

Based on the updated regulation, the Done. team has now adapted to meet the needs of how society has shifted by providing a combination of in-person and virtual care. In 2020, given the velocity of patient demand as well as the need to accommodate regulations for virtual care licensing and prescribing, the physical and economic barriers to access, particularly in underserved communities, were eliminated. Now, post-pandemic, and given our original mission to meet patients when and where they are, we are doing just that – offering the best in both in-person and virtual care through Done. offices and partnerships to serve patients with holistic psychiatric care that goes beyond ADHD treatment. As the means to distribute care shifts, so, too, is the nature of the treatment. Done. first committed to better access and efficiency for ADHD care.

Today, we’ve built a technology platform that sets a higher standard for patient care, and while we believe that our specialization in ADHD allows us to achieve better clinical outcomes and safer patient care, we are now ready to expand into a holistic approach that focuses on a wider range of psychiatric challenges.

Working in tandem with in-person medical practitioners, the Done. platform arms clinicians with deeper data and insights to ensure accurate diagnoses and allow monitoring of patient use of prescribed drugs to ensure proper dosage and mitigate potential abuse. The Done. platform leads the way to encapsulate how technology can improve the quality and effectiveness of healthcare services to make life better for patients.

As Done. scales our hybrid model nationally to all members, we are taking all necessary precautions to ensure a smooth transition for our patients and will keep them informed throughout the process. To learn more about the platform, visit DoneFirst.com.

About Done.

Done. is a hybrid-care (in-person + virtual) health platform that empowers anyone living with mental health challenges to reach their fullest potential. Through a patient-first, technology-powered platform, industry-leading digital-health company, Done. makes high-quality psychiatric chronic care management more accessible and affordable. Disclaimer: Done. is an online platform that connects members with qualified clinicians to screen, diagnose, and treat members with ADHD. Done. does not provide medical services. All professional services on the Done. platform are provided by clinicians who are psychiatric board-certified medical professionals;

Done. does not engage in the prescription business.

Share article on social media or email:

U.S. Dermatology Partners Announces the Opening of Gainesville, Texas Office


Gainesville, Texas Dermatologist

U.S. Dermatology Partners Gainesville

“We are excited to offer Gainesville residents dermatological services. CEO Paul Singh said this new office will give these patients access to preventative care options that will enhance their overall well-being and allow them to obtain prompt diagnosis and treatment options for skin cancer.”

U.S. Dermatology Partners is pleased to announce the opening of its newest office location in Gainesville, Texas. The new office is part of the organization’s Outreach Program serving rural and underserved communities. It will offer convenient access to dermatology and skin cancer treatments to patients in Cooke County beginning April 17th. The office will treat patients of all ages for a range of dermatologic conditions, including acne, psoriasis, eczema, and skin cancer.

Patients seeking dermatological treatment in rural areas may face prolonged wait times or need to commute for an hour or longer to reach the nearest practitioners in urban or suburban areas. To mitigate this issue, U.S. Dermatology Partners has taken the initiative to launch more than 30 new offices across eight states. These offices, including the one in Gainesville, will make it more convenient for rural patients to receive vital dermatological care. Certified Physician Assistant, Kenneth Spencer, will be the primary practitioner at the Gainesville office with oversight from Board-Certified Dermatologist, Dr. Clint Moss.

According to Paul Singh, the CEO of U.S. Dermatology Partners, “We are excited to offer our premier dermatological services to residents of Gainesville and Cooke County. This new office will give these patients access to preventative care options that will enhance their overall well-being and allow them to obtain prompt diagnosis and treatment options for skin cancer and other severe illnesses when they are in their earliest, more manageable stages.”

Today’s announcement builds on U.S. Dermatology Partners’ recent openings of offices in Sulphur Springs, Texas, Forney, Texas, and Muskogee, Oklahoma, which expand on their efforts to reach more patients, delivering high-quality care, throughout the country.

Located in the Texoma region of North Texas, Gainesville is the county seat of Cooke County. This thriving community offers a variety of specialty shops, dining locations, arts and entertainment, and outdoor recreation opportunities. A favorite among these is the Frank Buck Zoo. Founded in 1930 as the Gainesville Community Circus, the Frank Buck Zoo is located within the 30 acres of Leonard Park and is home to more than 130 animals. In 2020, the zoo won an award from the Zoological Association of America for its renovated prairie dog enclosure.

The new Gainesville office is conveniently located at 427 N. Grand Avenue, Gainesville, TX 76240. The new Gainesville office accepts Medicare and Medicare Supplement programs as well as most national medical insurances including Blue Cross Blue Shield, United Healthcare, Cigna, and Aetna, as well as regional insurances including Amerigroup. For more information or to schedule an appointment call (940) 584-1014 or click here to request an appointment online.

About U.S. Dermatology Partners

U.S. Dermatology Partners is one of the premier dermatology practices in the country, caring for more than 1.5 million patients each year. With nearly 100 locations across eight states that span large metroplexes and rural, underserved communities, they provide the benefits of private, personalized levels of care paired with a network of coordinated, specialized dermatology physicians. U.S. Dermatology Partners is fervently focused on providing the highest level of compassionate and comprehensive patient-first care, making it seamless for all people to connect with dermatologists and national leaders in areas such as clinical research, psoriasis, and Mohs surgery, and gain access to state-of-the-art dermatological treatments, surgical and cosmetic dermatology.

To learn more, visit usdermatologypartners.com.

Share article on social media or email:

Unitek Learning Strives to Combat Nursing Workforce Shortages


Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, Provo College, and Brookline College.

Access to healthcare is one of the biggest challenges that rural communities face.

Unitek Learning is thrilled to announce that Dr. Victoria Rondez Squier, the Practical Nursing Program Director in Reno, Nevada, has been highlighted as a pioneering leader in the Nevada Nursing Association (NNA) Newsletter. Access to healthcare is one of the biggest challenges that rural communities face. With a deficit of more than 5,000 nurses in the state, Nevada rural communities are greatly impacted by the nation-wide nursing shortage. One of Dr. Squier’s primary goals is to break down barriers that are faced by educators and practitioners in these areas.

“We are so proud of Dr. Squier’s work in rural nurse recruitment,” said Janis Paulson, Chief Executive Officer at Unitek Learning. “Through government-funded grants and incentives for career development, this call-to-action could help combat workforce shortage crises and better support communities across Nevada. We believe equity, inclusion, and innovation are vital when it comes to supporting the future of healthcare.”

The Nevada nursing community now has an additional partner to help retain more nurses. Joseph Filippi, Jr., the Workforce Program Manager with the Nevada Rural Hospital Partners, manages the Nurse Apprentice Program (NAP) Grant, which is funded by the U.S. Department of the Treasury American Rescue Plan ACT (ARPA). According to the NNA newsletter, a grant of $20,000,000 has been allotted to the NAP to attract nursing students in Nevada. These targeted regions include rural critical access hospitals and skilled nursing facilities.

“Additional training around research and advocacy may be necessary to obtain new hires,” said Dr. Squier, Practical Nursing Program Director at Unitek College. “The NAP is a partnership opportunity that begins to address the unique needs of our nurses in remote communities. When I think about these nursing prospects, I am so excited for the future of healthcare and nurses in rural areas. It is truly an honor to represent Unitek and advocate our shared purpose, vision, and core values.”

Dr. Victoria Rondez Squier, DNP, MSN, RN, CNL, NE-BC, EBP-C, is a results-driven leader with more than 16 years of experience in acute care. Some of her areas of expertise include orthopedics, oncology, telemetry, pediatrics, telehealth, and leadership. Throughout her career, Dr. Squier has served as a nurse leader who is passionate about preparing future generations of nurses. In addition, she is the president elect of the Nevada Nurses Association (NNA) in District 1. Dr. Squier is now the Practical Nursing Program Director for Unitek College in Reno, Nevada.

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, Provo College, and Brookline College. Unitek programs teach the clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in healthcare and nursing.

Share article on social media or email: